Techniques for eliciting mucosal immune response - PubMed (original) (raw)
Review
Techniques for eliciting mucosal immune response
R H Waldman et al. Acta Endocrinol Suppl (Copenh). 1975.
Abstract
Development of techniques for eliciting an immune response on mucosal surfaces is a relatively new area of clinical research. With the recognition of the existence of secretory immunity, independent of the systemic system, there was renewed interest in re-examining the conventional approach for optimal immunization techniques. A large body of data indicate that the majority of the secretory immunoglobulins and antibody produced to antigenic stimulation of mucosal surfaces is locally produced. Thus, antibody to C. albicans in the cervical or vaginal mucus has been shown to be of local origin and it predominantly belongs to the secretory IgA immunoglobulin class. The mechanism of antigen processing by the secretory surface leading to antibody formation remains a mystery, but it might be determined by the selective localization of antigens in the reticuloendothelial cells of the lamina propria, bronchi or small intestine. Usually application of antigen topically to the mucosal surface elicits local antibody formation to a greater extent than does parenteral immunization. On the other hand, a more pronounced systemic immune response is seen when the antigen is administered systemically. However, a number of other factors determine the quality and quantity of the immune response, e.g., the physical state of the antigen, live vs killed vaccine, dose, adjuvant, previous exposure to similar or cross-reacting antigens, and site of application of the antigen. These factors are discussed in the review. Recent observations suggest that cell mediated immunity is a component of the secretory immune system, and like the humoral mechanism, also may be partially compartmentalized.
Similar articles
- Cell-mediated immunity and antibody responses in the respiratory tract after local and systemic immunization.
Waldman RH, Henney CS. Waldman RH, et al. J Exp Med. 1971 Aug 1;134(2):482-94. doi: 10.1084/jem.134.2.482. J Exp Med. 1971. PMID: 4997741 Free PMC article. - Intravaginal immunization of humans with Candida albicans.
Waldman RH, Cruz JM, Rowe DS. Waldman RH, et al. J Immunol. 1972 Oct;109(4):662-4. J Immunol. 1972. PMID: 4627506 No abstract available. - Local immunological response in the vagina, cervix and endometrium.
Vaerman JP, Férin J. Vaerman JP, et al. Acta Endocrinol Suppl (Copenh). 1975;194:281-305. Acta Endocrinol Suppl (Copenh). 1975. PMID: 1092117 Review. - Absence of IgA antibody to herpesvirus in cervicovaginal secretions of patients with carcinoma of the cervix.
Dent PB, Bienenstock J. Dent PB, et al. Clin Immunol Immunopathol. 1974 Nov;3(2):171-7. doi: 10.1016/0090-1229(74)90002-6. Clin Immunol Immunopathol. 1974. PMID: 4615850 No abstract available. - Prospects for human mucosal vaccines.
Mestecky J, McGhee JR. Mestecky J, et al. Adv Exp Med Biol. 1992;327:13-23. doi: 10.1007/978-1-4615-3410-5_3. Adv Exp Med Biol. 1992. PMID: 1295333 Review.
Cited by
- Demonstration of IgG Fc receptors on spermatozoa and their utilization for the detection of circulating immune complexes in human serum.
Witkin SS, Shahani SK, Gupta S, Good RA, Day NK. Witkin SS, et al. Clin Exp Immunol. 1980 Sep;41(3):441-52. Clin Exp Immunol. 1980. PMID: 6160008 Free PMC article. - Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans.
Czerkinsky C, Svennerholm AM, Quiding M, Jonsson R, Holmgren J. Czerkinsky C, et al. Infect Immun. 1991 Mar;59(3):996-1001. doi: 10.1128/iai.59.3.996-1001.1991. Infect Immun. 1991. PMID: 1997444 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous